Cochrane Gut was formed in June 2020 by the merger of Cochrane Upper Gastrointestinal and Pancreatic Diseases and Cochrane IBD. We aim to synthesize evidence to answer practical questions on the diagnosis, prevention, treatment and rehabilitation of diseases of the gastrointestinal system. This includes disorders of the oesophagus, stomach, duodenum, pancreas and bowel. We oversee a large portfolio of reviews related to inflammatory bowel disease, both ulcerative colitis and Crohn's disease. The group also considers reviews pertaining to functional bowel diseases of the gut, as well as reviews that cover both adults and children. We are based at McMaster University within the Faculty of Medicine - Gastroenterology Division.
Company Details
- Employees
- 2
- Address
- 1280 Main St W, Hsc 3n51c,canada
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://www.gut.cochrane.org
- HQ
- Hamilton, Ontario
Cochrane Gut Questions
Cochrane Gut's website is http://www.gut.cochrane.org
Cochrane Gut's LinkedIn profile is https://ca.linkedin.com/company/cochrane-gut
Cochrane Gut has
2 employees.
View email and phone details for 2
employees at Cochrane Gut.
Cochrane Gut's industry is
Research Services
Cochrane Gut's categories are Research Services
